Amoxicillin Tablet, Coated
Product Images NDC 50090-5863

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amoxicillin (NDC 50090-5863). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (Amoxicillin Tablets Usp 875 mg 1)

This text is a table that provides dosing recommendations for adult and pediatric patients over 3 months of age for various types and severity of infections caused by bacteria. It specifies the usual adult dose and the usual dose for children, depending on the infection severity, for ear, nose and throat, skin and skin structure, genitourinary tract, lower respiratory tract, and gonorrhea infections. The table also includes a note on the dosing regimen for infections caused by bacteria intermediate in their susceptibility to amoxicillin and a cautionary note to avoid using a certain regimen in children under two years old.*

FDA Label Image

Structural Image (Amoxicillin Tablets Usp 875 mg 2)

The text is not-available as it is just a formula.*

FDA Label Image

Table 3 (Amoxicillin Tablets Usp 875 mg 3)

Table 3 shows the average pharmacokinetic parameters of amoxicillin in healthy adults who were given 400 mg of amoxicillin either as a 5 mL suspension or one chewable tablet with a light meal. The mean values of 24 participants were recorded, and the peak concentrations occurred around an hour after the administration. The AUC and cha values differed for both administration methods.*

FDA Label Image

Bacteria (Amoxicillin Tablets Usp 875 mg 4)

This is a list of different types of bacteria classified into two main groups: Gram-Positive and Gram-Negative. The Gram-Positive category includes Enterococous faecalis, Staphylococcus spp., Streptococcus pneumoniae, and a few types of hemolytic streptococci. The Gram-Negative group consists of Escherichia coli, Haemophilus influenzae, Neisseria gonorthoeae, Proteus mirabilis, and Helicobacter pylori. This list is likely from a scientific or medical source as it identifies specific bacteria and groups them by their Gram classification.*

FDA Label Image

Table 6 (Amoxicillin Tablets Usp 875 mg 5)

Table 6 shows the results of two studies analyzing H. pylori eradication rates using triple therapy that includes amoxicillin. The analysis is based on patients with confirmed duodenal ulcers and H. pylori infection at baseline. Patients who completed the study and those who dropped out due to adverse events were included in the analysis. The results are presented for evaluable patients and the intent-to-treat analysis, along with confidence intervals. This information can be useful for medical professionals treating H. pylori infections with triple therapy.*

FDA Label Image

Table 7 (Amoxicillin Tablets Usp 875 mg 6)

FDA Label Image

Label Image (Lbl500905863)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.